Revolo Biotherapeutics Awarded Innovation Passport for '1805 in the United Kingdom for the Treatment of Moderate to Severe Rheumatoid Arthritis

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

United Kingdom ,London ,City Of ,Jonathan Rigby ,Revolo Biotherapeutic ,Revolo Biotherapeutics ,Revolo Bio ,Marylyn Rigby ,Monica Rouco Molina ,Revolo Biotherapeutics Bio ,Public Reference Group ,Company Contact ,Toxicology Centre ,Regulatory Agency ,National Institute For Health ,Lifesci Communications ,Steering Group ,Scottish Medicines Consortium ,Innovative Medicines Designation ,Innovation Passport ,Rheumatoid Arthritis ,Innovative Licensing ,Access Pathway ,Innovation Passport Designation ,Chief Executive Officer ,Innovative Medicine Designation ,National Institute ,Care Excellence ,All Wales Therapeutics ,Public Reference ,Rouco Molina ,Health ,Business ,Europe ,Globe Newswire ,Arthritis ,